铁代谢障碍通过诱导氧化应激损伤促进排卵后卵细胞衰老
Ziqi Huang1, Bicheng Wang1, Ying Tian1
1Department of Histology and Embryology, School of Basic Medical Sciences, Capital Medical University, Beijing 100069, China.
Life medicine
|December 26, 2025
概括
铁代谢中断驱动反应性氧物种 (ROS) 积累和老化小鼠卵细胞中的细胞损伤. 铁化疗有效地减轻了这些与年龄相关的退行性变化,并改善了生殖潜力.
科学领域:
- 生殖生物学 生殖生物学
- 细胞衰老 细胞衰老
- 铁的新陈代谢 铁的新陈代谢
背景情况:
- 活性氧物种 (ROS) 与卵细胞衰老有关,但ROS积累的机制尚不清楚.
- 了解铁的作用对于解决与年龄相关的卵细胞质量下降至关重要.
研究的目的:
- 为了研究铁代谢状态及其与小鼠卵细胞在排卵后衰老期间与ROS的相关性.
- 探索针对铁失调的潜在治疗干预措施.
主要方法:
- 在卵巢组织中对血氧酶1 (HO-1) 表达的分析.
- 在卵细胞中评估铁含量和铁代谢蛋白的表达 (FHC,FtMT,DMT1,FPN1,IRP2,TFR1).
- 评估细胞损伤标志物 (细胞质自由Fe2+,脂质过氧化,DNA损伤,线粒体/溶酶体功能,/染色体对齐).
- 用德胺 (DFO) 和原 (ZnPP) 治疗,以评估干预的有效性.
主要成果:
- 在体内,排卵后的衰老导致HO-1表达的增加和卵细胞中铁代谢的失调.
- 与实验室中老化的对应细胞相比,老化的卵细胞表现出高铁水平,改变了与铁相关的蛋白质表达和显著的细胞损伤.
- 德菲洛克萨明 (DFO) 和HO-1抑制剂原 (ZnPP) 改善了与衰老相关的变化,改善了卵细胞质量.
- 这些干预措施提高了受精能力和植入前发展.
结论:
- 铁稳定性障碍对ROS积累和排卵后衰老卵细胞的退行性变化有显著的贡献.
- 铁化是一种有前途的治疗策略,可以抵消卵细胞衰老并改善生育结果.
相关概念视频
Oogenesis
68.8K
In human women, oogenesis produces one mature egg cell or ovum for every precursor cell that enters meiosis. This process differs in two unique ways from the equivalent procedure of spermatogenesis in males. First, meiotic divisions during oogenesis are asymmetric, meaning that a large oocyte (containing most of the cytoplasm) and minor polar body are produced as a result of meiosis I, and again following meiosis II. Since only oocytes will go on to form embryos if fertilized, this unequal...
68.8K
Oogenesis
3.6K
Oogenesis, the process of developing egg cells (female gametes), occurs within the ovaries and is fundamental to female fertility. This sequence begins during fetal development when diploid oogonia in the developing ovaries undergo mitotic divisions to produce primary oocytes. By birth, these primary oocytes enter prophase I of meiosis but become arrested in this stage, remaining suspended until puberty.
Each primary oocyte is surrounded by a layer of pre-granulosa cells, forming what is...
Each primary oocyte is surrounded by a layer of pre-granulosa cells, forming what is...
3.6K
Hormonal Control of the Ovarian Cycle
6.3K
The ovarian cycle is meticulously regulated by the hypothalamic-pituitary-gonadal axis. This cycle orchestrates the release of a mature oocyte, essential for reproduction.
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle. At puberty, GnRH secretion increases in both frequency and...
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle. At puberty, GnRH secretion increases in both frequency and...
6.3K
Menopause
3.5K
Menopause, a natural biological process marking the end of a woman's fertility, typically occurs between the fifth and sixth decade of life. This phase is characterized by the exhaustion of the ovarian follicle pool, leading to less responsive ovaries despite the high levels of Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH). The consequential decrease in estrogen production results in symptoms like hot flashes, heavy sweating, headaches, hair loss, muscle pains, vaginal...
3.5K
Bone Disorders
5.0K
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
5.0K
Factors Affecting Erythropoiesis
5.4K
The cardiovascular system regulates the number of erythrocytes in the bloodstream to ensure optimal oxygen transport. It also prevents over-proliferation of these cells, which helps to maintain blood viscosity and flow rate.
Several factors influence the erythrocyte production rate, with tissue oxygen level being among the most critical. Intense exercise or high altitudes can cause tissue hypoxia, which triggers the kidneys to release more erythropoietin (EPO) into the bloodstream.
EPO then...
Several factors influence the erythrocyte production rate, with tissue oxygen level being among the most critical. Intense exercise or high altitudes can cause tissue hypoxia, which triggers the kidneys to release more erythropoietin (EPO) into the bloodstream.
EPO then...
5.4K


